相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitive activities detection of monoamine oxidases (MAO) A and B inhibitors in human liver MAO incubations by UPLC-ESI-MS/MS
Bo Jiang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
New electrochemical method for the determination of β-carboline alkaloids, harmalol and harmine, in human urine samples and in Banisteriopsis caapi
Dalibor Stankovic et al.
MICROCHEMICAL JOURNAL (2015)
Inhibition of in vitro metabolism of testosterone in human, dog and horse liver microsomes to investigate species differences
Jana Zielinski et al.
TOXICOLOGY IN VITRO (2015)
Regioselective Glucuronidation of Andrographolide and Its Major Derivatives: Metabolite Identification, Isozyme Contribution, and Species Differences
Xiangge Tian et al.
AAPS JOURNAL (2015)
Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae)
Sihem Bensalem et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Metabolites identification of harmane in vitro/in vivo in rats by ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry
Shuping Li et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Rapid and sensitive detection of the inhibitive activities of acetyl- and butyryl-cholinesterases inhibitors by UPLC-ESI-MS/MS
Wei Liu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Comparative metabolism of benfuracarb in in vitro mammalian hepatic microsomes model and its implications for chemical risk assessment
Khaled Abass et al.
TOXICOLOGY LETTERS (2014)
Bioactivation of 3-n-Butylphthalide via Sulfation of Its Major Metabolite 3-Hydroxy-NBP: Mediated Mainly by Sulfotransferase 1A1
Xingxing Diao et al.
DRUG METABOLISM AND DISPOSITION (2014)
Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients
Cen Xie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Simultaneous determination of harmine, harmaline and their metabolites-harmol and harmalol in beagle dog plasma by UPLC-ESI-MS/MS and its application to a pharmacokinetic study
Lei Zhang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy
Ting Zhao et al.
FOOD CHEMISTRY (2012)
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients
Amandeep Mann et al.
NEUROBIOLOGY OF AGING (2012)
Inhibition of Human Cytochrome P450 Enzymes 3A4 and 2D6 by β-Carboline Alkaloids, Harmine Derivatives
Ting Zhao et al.
PHYTOTHERAPY RESEARCH (2011)
Metabolism of Tanshinol Borneol Ester in Rat and Human Liver Microsomes
Duan Liu et al.
DRUG METABOLISM AND DISPOSITION (2010)
Relationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls
Elan D. Louis et al.
NEUROTOXICOLOGY (2010)
Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model
Chao Wu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Cytotoxicity of the β-carboline alkaloids harmine and harmaline in human cell assays in vitro
Judith Jimenez et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2008)
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
Marcella Martignoni et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Validated assays for human cytochrome P450 activities
RL Walsky et al.
DRUG METABOLISM AND DISPOSITION (2004)
Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic β-carboline alkaloids harmaline and harmine
AM Yu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates
MJ Graham et al.
XENOBIOTICA (2003)
Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions
DFV Lewist et al.
XENOBIOTICA (2002)
Cytochromes P450 and experimental models of drug metabolism
R Zuber et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats
YB Guan et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A (2001)
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
JA Goldstein
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man
JJP Bogaards et al.
XENOBIOTICA (2000)
分享论文
